CORD-19:4abc50cfc81265083d4cb2aed0a493bb704d0b5b / 51068-51233 JSONTXT

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T206","span":{"begin":25,"end":31},"obj":"Disease"},{"id":"T15817","span":{"begin":25,"end":31},"obj":"Disease"}],"attributes":[{"id":"A206","pred":"mondo_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/MONDO_0019173"},{"id":"A66566","pred":"mondo_id","subj":"T15817","obj":"http://purl.obolibrary.org/obo/MONDO_0019173"}],"text":"Consequently, a BsAb for rabies treatment could be constructed with one arm targeting one of the endogenous BBB receptors while the other targets the RABV G protein."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T252","span":{"begin":0,"end":165},"obj":"Sentence"},{"id":"T45420","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Consequently, a BsAb for rabies treatment could be constructed with one arm targeting one of the endogenous BBB receptors while the other targets the RABV G protein."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T49","span":{"begin":72,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A49","pred":"uberon_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"}],"text":"Consequently, a BsAb for rabies treatment could be constructed with one arm targeting one of the endogenous BBB receptors while the other targets the RABV G protein."}